StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Bavencio alliance revenue [legacy through FY23] by Quarter

Bavencio alliance revenue [legacy through FY23] ($M) ($M)

QuarterlyAnnual

Pfizer Bavencio alliance revenue [legacy through FY23]: $4M in Q4 2023, down 94.5% from a year earlier. That is the lowest of the 14 quarters on record here. No newer figure appears in the documents we track.

Latest, Q4 2023
4
Period ended Dec 31, 2023
Change on a year earlier
-94.5%
73 in Q4 2022
History
14 quarters
Since Q3 2020
Sources
9
Documents cited below

Where the Q4 2023 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2024-02-22) ↗

Reported in Form 10-K Segment Note.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBavencio alliance revenue [legacy through FY23] ($M) ($M)Year on yearSource
Q4 2023Dec 31, 20234-94.5%Form 10-K (filed 2024-02-22) ↗
Q3 2023Oct 1, 202318-75.3%Form 10-Q (filed 2023-11-08) ↗
Q2 2023Jul 2, 202383+43.1%Form 10-Q (filed 2023-08-09) ↗
Q1 2023Apr 2, 202385+26.9%Form 10-Q (filed 2023-05-10) ↗
Q4 2022Dec 31, 202273+30.4%Form 10-K (filed 2024-02-22) ↗
Q3 2022Oct 2, 202273+35.2%Form 10-Q (filed 2023-11-08) ↗
Q2 2022Jul 3, 202258+56.8%Form 10-Q (filed 2023-08-09) ↗
Q1 2022Apr 3, 202267+109.4%Form 10-Q (filed 2023-05-10) ↗
Q4 2021Dec 31, 202156+93.1%Form 10-K (filed 2024-02-22) ↗
Q3 2021Oct 3, 202154+157.1%Form 10-Q (filed 2022-11-09) ↗
Q2 2021Jul 4, 202137–Form 10-Q (filed 2022-08-10) ↗
Q1 2021Apr 4, 202132–Form 10-Q (filed 2022-05-11) ↗
Q4 2020Dec 31, 202029–Form 10-K (filed 2023-02-23) ↗
Q3 2020Sep 27, 202021–Form 10-Q (filed 2021-11-12) ↗

Cite this data

StockData. (2026). Pfizer Bavencio alliance revenue [legacy through FY23] ($M), quarterly Q3 2020–Q4 2023 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/bavencio-leg

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.